IL20RA and breast cancer: Interleukin 20 receptor subunit alpha (IL20RA) increases the ratio of SP to ALDHbr in breast cancer cells, improves sphere-forming capacity, stimulates the production of key stem cell genes such as Sox2 and Oct4, and boosts chemoresistance.